Major depressive disorder and inflammatory markers in elderly patients with heart failure

Psychosomatics

Volumn 48, Issue 4, 2007, Pages 319-324

  Andrei, Anna Maria ^a   Fraguas Jr , Renerio ^a   Telles, Renata M S ^a   Alves, Tânia C T F ^a   Strunz, Celia M C ^a   Nussbacher, Amit ^a   Rays, Jairo ^a   Iosifescu, Dan V ^a   Wajngarten, Mauricio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DIGOXIN; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; NITRIC ACID DERIVATIVE; SPIRONOLACTONE; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INFLAMMATION; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; STATISTICAL SIGNIFICANCE;

EID: 34347252671     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.48.4.319     Document Type: Article

References (63)

1. National Center for Health Statistics GE Summary: National Hospital Discharge Survey: Advance Data From Vital and Health Statistics, Number 199. Hyattsville, MD, U.S. Public Health Service, 1991, pp 1-12
2. Wells KB, Stewart A, Hays RD, et al: The functioning and well-being of depressed patients: results from The Medical Outcomes Study. JAMA 1989; 262:914-919
3. Schulz R, Beach SR, Ives DG, et al: Association between depression and mortality in older adults: The Cardiovascular Health Study. Arch Intern Med 2000; 160:1761-178
4. Wassertheil-Smoller S, Applegate WB, Berge K, et al: Change in depression as a precursor of cardiovascular events: SHEP Cooperative Research Group (Systolic Hypertension in the Elderly). Arch Intern Med 1996; 156:553-561
5. Jiang W, Alexander J, Christopher E, et al: Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001; 161:1849-1856
6. Rumsfeld JS, Havranek E, Masoudi FA, et al: Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol 2003; 42:1811-187
7. Parissis JT, Adamopoulos S, Rigas A, et al: Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with-versus-without symptoms of depression. Am J Cardiol 2004; 94:1326-138
8. Havranek EP, Ware MG, Lowes BD: Prevalence of depression in congestive heart failure. Am J Cardiol 1999; 84:348-350, A9
9. Skotzko CE, Krichten C, Zietowski G, et al: Depression is common and precludes accurate assessment of functional status in elderly patients with congestive heart failure. J Card Fail 2000; 6:300-305
10. Faris R, Purcell H, Henein MY, et al: Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail 2002; 4:541-551
11. Turvey CL, Schultz K, Arndt S, et al: Prevalence and correlates of depressive symptoms in a community sample of people suffering from heart failure. J Am Geriatr Soc 2002; 50:2003-2008
12. Koenig HG: Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry 1998; 20:29-43
13. Vaccarino V, Kasl SV, Abramson J, et al: Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001; 38:199-205
14. Freedland KE, Rich MW, Skala JA, et al: Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med 2003; 65:119-128
15. Empana JP, Sykes DH, Luc G, et al: Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2005; 111:2299-2305
16. Steptoe A, Kunz-Ebrecht SR, Owen N: Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med 2003; 33:667-674
17. Danner M, Kasl SV, Abramson JL, et al: Association between depression and elevated C-reactive protein. Psychosom Med 2003; 65:347-356
18. Sluzewska A, Rybakowski J, Bosmans E, et al: Indicators of immune activation in major depression. Psychiatry Res 1996; 64:161-167
19. Ford DE, Erlinger TP: Depression and C-reactive protein in U.S. adults: data from The 3rd National Health and Nutrition Examination Survey. Arch Intern Med 2004; 164:1010-1014
20. Pye M, Rae AP, Cobbe SM: Study of serum C-reactive protein concentration in cardiac failure. Br Heart J 1990; 63:228-230
21. Berk M, Wadee AA, Kuschke KH, et al: Acute phase proteins in major depression. J Psychosom Res 1997; 43:529-534
22. Wisniacki N, Taylor W, Lye M, et al: Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure. Heart 2005; 91:32-37
23. Levine B, Kalman J, Mayer L, et al: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323:236-241
24. Penninx BW, Kritchevsky SB, Yaffe K, et al: Inflammatory markers and depressed mood in older persons: results from The Health, Aging, and Body Composition Study. Biol Psychiatry 2003; 54:566-572
25. 6 is an important prognostic predictor in patients with congestive heart failure. J Am Coll Cardiol 1998; 31:391-398
26. Torre-Amione G, Kapadia S, Benedict C, et al: Proinflammatory cytokine levels in patients with depressed left-ventricular ejection fraction: a report from The Studies of Left-Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996; 27:1201-1206
27. 2, and transferrin receptor in major depression. J Affect Disord 1995; 34:301-309
28. Connor TJ, Leonard BE: Depression, stress, and immunological activation: the role of cytokines in depressive disorders. Life Sci 1998; 62:583-606
29. Calderone A, Thaik CM, Takahashi N, et al: Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest 1998; 101:812-818
30. 1β modulates the growlh and phenotype of neonatal rat cardiac myocytes. J Clin Invest 1995; 96:1093-109
31. α-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell deaih. J Clin Invest 1996; 98:2854-2865
32. β. J Clin Invest 1995; 95:677-685
33. Hare JM, Colucci WS: Role of nitric oxide in the regulation of myocardial function. Prog Cardiovasc Dis 1995; 38:155-166
34. Givertz MM, Colucci WS: New targets for heart-failure therapy: endothelin, inflammatory cytokines, and oxidative stress. Lancet 1998; 352(suppl 1):S134-S138
35. Pober JS, Cotran RS: Cytokines and endothelial cell biology. Physiol Rev 1990; 70:427-451
36. Yoshizumi M, Perrella MA, Burnett JC Jr, et al: Tumor necrosis factor down-regulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 1993; 73:205-209
37. 6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 1993; 49:11-27
38. Dantzer R: Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 2001; 933:222-234
39. 6 inhibition attenuate the pro-atherogenic effects of C-reactive protein. Circulation 2002; 105:1890-186
40. Pasceri V, Willerson JT, Yeh ET: Direct pro-inflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102:2165-218
41. Miller GE, Stetler CA, Carney RM, et al: Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002; 90:1279-1283
42. Douglas KM, Taylor AJ, O'Malley PG: Relationship between depression and C-reactive protein in a screening population. Psychosom Med 2004; 66:679-683
43. Koenig W: C-reactive protein: risk assessment in the primary prevention of atherosclerotic disease: has the time come for including it in the risk profile? Ital Heart J 2001; 2:157-163
44. Annique S, Dorien T, Richel L, et al: Inflammatory markers in depressed post-myocardial infarction patients. J Psychiatr Res 2005; 39:137-144
45. 6, and C-reactive protein in patients with recent acute coronary syndromes. Am J Psychiatry 2004; 161:271-277
46. Appels A, Bar FW, Bar J, et al: Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med 2000; 62:601-605
47. Tavares M: Entrevista Clínica Estruturada para o DSM-IV-Transtornos do Eixo I, Ediçao Para Pacientes, SCID-I/P (Versão 2.0). Brasília, DF, Brazil: Instituto de Psicologia-Universidade de Brasília; 1996
48. α in nine patients with dilated cardiomyopathy. J Cardiol 2002; 39:253-257
49. Chen JW, Lin FY, Chen YH, et al: Carvedilol inhibits tumor necrosis factor-induced endothelial transcription factor activation, adhesion molecule expression, and adhesiveness to human mononuclear cells. Arterioscler Thromb Vasc Biol 2004; 24:2075-2081
50. First SR, Gibbson M, Williams JBW: Structured Clinical Interview for Axis I DSM-IV Disorders (Version 2.0), Patient Edition. New York, Biometrics Research Dept., NY State Psychiatric Institute, 1995
51. Jialal I, Stein D, Balis D, et al: Effect of hydroxymethyl glutaryl coenzyme A reductase-inhibitor therapy on high-sensitive C-reactive protein levels. Circulation 2001; 103:1933-1935
52. Denollet J, Conraads VM, Brutsaert DL, et al: Cytokines and immune activation in systolic heart failure: the role of Type D personality. Brain Behav Immun 2003; 17:304-309
53. 6 in severe heart failure. Am J Cardiol 1997; 79:1128-1131
54. 6 in patients with acute left heart decompensation. Clin Cardiol 1999; 22:811-813
55. Testa M, Yeh M, Lee P, et al: Circulating levels of cytokines and their endogenous modulators in patients with mild-to-severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996; 28:964-971
56. Kop WJ, Gottdiener JS, Tangen CM, et al: Inflammation and coagulation faclors in persons over 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002; 89:419-424
57. Ridker PM, Buring JE, Shih J, et al: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98:731-733
58. Yin WH, Chen JW, Jen HL, et al: Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J: 2004; 147:931-938
59. Haverkate F, Thompson SG, Pyke SD, et al: Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349:462-466
60. Shehab AM, MacFadyen RJ, McLaren M, et al: Sudden unexpected death in heart failure may be preceded by short-term, intra-individual increases in inflammation and in autonomic dysfunction: a pilot study. Heart 2004; 90:1263-1268
61. Kaneko K, Kanda T, Yamauchi Y, et al: C-reactive protein in dilated cardiomyopathy. Cardiology 1999; 91:215-219
62. Tiemeier H, Hofman A, van Tuijl HR, et al: Inflammatory proteins and depression in the elderly. Epidemiology 2003; 14:103-107
63. Lyness JM, Moynihan JA, Caine ED: Inflammatory markers, depression, and cardiac disease. Am J Psychiatry 2005; 162:195; author reply, 195